<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref81">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kim</surname>
    <given-names>Y. I.</given-names>
   </name>
   <name>
    <surname>Pareek</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Murphy</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Harrison</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Farrell</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Cook</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2017</year>). 
  <article-title>The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin</article-title>. 
  <source>Influenza Other Respir. Viruses</source>
  <volume>11</volume>, 
  <fpage>525</fpage>â€“
  <lpage>530</lpage>. 
  <pub-id pub-id-type="doi">10.1111/irv.12503</pub-id>
  <pub-id pub-id-type="pmid">28990339</pub-id>
 </mixed-citation>
</ref>
